Free for academic non-profit institutions. Other users need a Commercial license
microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]
MIR6886 (MicroRNA 6886) is an RNA Gene, and is affiliated with the miRNA class. Diseases associated with MIR6886 include Homozygous Familial Hypercholesterolemia. Among its related pathways are Lipoprotein metabolism and Clathrin-mediated endocytosis.
GeneHancer (GH) Identifier | GH Type | GH Score |
GH Sources | Gene Association Score | Total Score | TSS distance (kb) | Number of Genes Away | Size (kb) | Transcription Factor Binding Sites |
Gene Targets |
---|---|---|---|---|---|---|---|---|---|---|
GH19J011114 | Enhancer | 0.6 | dbSUPER | 600.7 | +0.9 | 857 | 0.4 | ZNF692 SP1 POLR2A ZNF316 RBM22 JUND NR2F2 SIN3A ZFP69B SUPT5H | MIR6886 SPC24 piR-57460-346 LDLR | |
GH19J011111 | Enhancer | 0.5 | dbSUPER | 600.7 | -1.8 | -1763 | 0.5 | RBFOX2 POLR2A RBM22 SMAD5 SUPT5H POLR2B | MIR6886 piR-43107-137 LDLR SPC24 | |
GH19J011113 | Enhancer | 0.4 | dbSUPER | 600.7 | +0.0 | 4 | 0.9 | POLR2A RBM22 SUPT5H | MIR6886 TMEM205 piR-57460-346 LDLR SPC24 | |
GH19J011115 | Enhancer | 0.5 | dbSUPER | 0.7 | +3.0 | 2981 | 1.3 | POLR2A RBM22 SUPT5H POLR2B PML | SPC24 TMEM205 MIR6886 piR-57460-346 LDLR | |
GH19J011119 | Enhancer | 0.6 | dbSUPER | 0.4 | +7.0 | 6970 | 1.6 | IKZF1 RBFOX2 POLR2A EP300 FOXA2 ESRRA KDM1A RBM22 BCOR SUPT5H | SPC24 piR-57460-346 MIR6886 LDLR |
SuperPathway | Contained pathways | ||
---|---|---|---|
1 | Lipoprotein metabolism | ||
2 | Metabolism of fat-soluble vitamins | ||
3 | Folate Metabolism | ||
4 | Clathrin-mediated endocytosis | ||
5 | Vesicle-mediated transport |
RNAcentral Transcript ID | Subcategory | Length (nts) | # of Sources | Source Identifiers and Annotations |
---|---|---|---|---|
URS000075A1D9_9606 | precursor_RNA | 61 | 4 |
HGNC: 50121, RefSeq: NR_106946, Ensembl: ENST00000619864 (view in UCSC) , miRBase: MI0022733, |
URS000075D6A4_9606 | miRNA | 21 | 2 |
RefSeq: NR_106946, miRBase: MIMAT0027673, |
URS000075EF90_9606 | miRNA | 21 | 2 |
RefSeq: NR_106946, miRBase: MIMAT0027672, |
SNP ID | Clinical significance and condition | Chr 19 pos | Variation | AA Info | Type |
---|---|---|---|---|---|
654906 | Likely Pathogenic: Familial hypercholesterolemia | 11,113,445(+) | TGCAGGTGAGCGTCGC | SPLICE_DONOR_VARIANT | |
rs1003723 | Benign: Familial hypercholesterolemia 1 | 11,113,505(+) | C/T | NON_CODING_TRANSCRIPT_VARIANT,INTRON_VARIANT | |
rs1131692206 | Pathogenic: Familial hypercholesterolemia 1 | 11,113,510(+) | A/G | NON_CODING_TRANSCRIPT_VARIANT,INTRON_VARIANT | |
rs139617694 | Pathogenic/Likely Pathogenic: Familial hypercholesterolemia; Familial hypercholesterolemia 1; Homozygous familial hypercholesterolemia; Hypercholesterolaemia. Pathogenic/Likely Pathogenic: Familial hypercholesterolemia 1 | 11,113,534(+) | G/AG/C | SPLICE_ACCEPTOR_VARIANT,NON_CODING_TRANSCRIPT_VARIANT | |
rs1555805318 | Uncertain Significance: Familial hypercholesterolemia 1 | 11,113,508(+) | T/G | NON_CODING_TRANSCRIPT_VARIANT,INTRON_VARIANT |
Disorder | Aliases | PubMed IDs |
---|---|---|
homozygous familial hypercholesterolemia |
|
|